Profile	GDS3514 / 206286_s_at
Title	Liposarcoma response to doxorubicin in vitro
Organism	Homo sapiens

Graph caption help

Sample	Title	Value	Rank
GSM325240	Patient no. 1: control	112.839	30
GSM325241	Patient no. 1: treated	47.2413	15
GSM325242	Patient no. 9: control	176.879	36
GSM325243	Patient no. 9: treated	36.7296	13
GSM325244	Patient no. 18: control	22.2279	6
GSM325245	Patient no. 18: treated	42.702	13
GSM325246	Patient no. 12: control	49.6687	20
GSM325247	Patient no. 12: treated	25.5563	13
GSM325248	Patient no. 3: control	78.4896	27
GSM325249	Patient no. 3: treated	17.307	11
GSM325250	Patient no. 7: control	150.26	36
GSM325251	Patient no. 7: treated	51.9751	20
GSM325252	Patient no. 15: control	150.987	31
GSM325253	Patient no. 15: treated	68.2781	19
GSM325254	Patient no. 4: control	24.0551	10
GSM325255	Patient no. 4: treated	32.3126	12
GSM325256	Patient no. 19: control	115.586	30
GSM325257	Patient no. 19: treated	27.78	13
GSM325258	Patient no. 14: control	24.4004	8
GSM325259	Patient no. 14: treated	66.7865	17
GSM325260	Patient no. 13: control	45.109	14
GSM325261	Patient no. 13: treated	38.9083	11
GSM325262	Patient no. 17: control	29.0239	12
GSM325263	Patient no. 17: treated	277.505	44
GSM325264	Patient no. 10: control	197.492	39
GSM325265	Patient no. 10: treated	27.5896	10
GSM325266	Patient no. 5: control	20.3234	12
GSM325267	Patient no. 5: treated	99.2073	35
GSM325268	Patient no. 11: control	42.0928	13
GSM325269	Patient no. 11: treated	32.614	14
GSM325270	Patient no. 6: control	775.745	67
GSM325271	Patient no. 6: treated	60.5086	21
GSM325272	Patient no. 8: control	103.845	23
GSM325273	Patient no. 8: treated	46.805	15
GSM325274	Patient no. 16: control	50.9486	17
GSM325275	Patient no. 16: treated	39.7575	15
GSM325276	Patient no. 2: control	20.8936	7
GSM325277	Patient no. 2: treated	14.7471	11